Age Distribution of Influenza Like Illness Cases during Post-Pandemic A(H3N2): Comparison with the Twelve Previous Seasons, in France

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Turbelin, Clément ^a,b   Souty, Cécile ^a,b   Pelat, Camille ^a,c   Hanslik, Thomas ^d,e,f   Sarazin, Marianne ^a,b   Blanchon, Thierry ^a,b   Falchi, Alessandra ^a,g  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f HÔPITAL AMBROISE PARÉ   (France)

^g UNIVERSITÉ DE CORSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; DISEASE SURVEILLANCE; EPIDEMIC; FLU LIKE SYNDROME; FRANCE; GENERAL PRACTICE; HUMAN; INFANT; INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; NONHUMAN; PANDEMIC INFLUENZA; PRESCHOOL CHILD; SCHOOL CHILD; SEASONAL INFLUENZA; TREND STUDY; IMMUNOLOGY; INCIDENCE; INFLUENZA VIRUS A H3N2; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMIC; SEASON; VACCINATION; YOUNG ADULT;

CERCOPITHECINE HERPESVIRUS 1; INFLUENZA A VIRUS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CHILD, PRESCHOOL; FRANCE; HUMANS; INCIDENCE; INFANT; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMICS; SEASONS; VACCINATION; YOUNG ADULT;

EID: 84878755332     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065919     Document Type: Article

References (44)

1. Cox NJ, Subbarao K, (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51: 407-421.
2. Kaji M, Watanabe A, Aizawa H, (2003) Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients. Respirology 8: 231-233.
3. Rambaut A, Pybus OG, Nelson MI, Viboud C, Taubenberger JK, et al. (2008) The genomic and epidemiological dynamics of human influenza A virus. Nature 453: 615-619.
4. Fouillet A, Merlen R, Rey G, Cardoso T, Caserio-Schnönemann C (2012) [Surveillance of mortality in France during the 2011-2012 winter]. BEH: 375-379.
5. (2012) European Centre for Disease Prevention and Control. Seasonal influenza 2011-2012 in Europe. Risk assessment. Stockholm: ECDC.
6. Ferguson NM, Galvani AP, Bush RM, (2003) Ecological and immunological determinants of influenza evolution. Nature 422: 428-433.
7. Smith DJ, Lapedes AS, de Jong JC, Bestebroer TM, Rimmelzwaan GF, et al. (2004) Mapping the antigenic and genetic evolution of influenza virus. Science 305: 371-376.
8. Bonmarin I, Belchior E, Le Strat Y, Levy-Bruhl D (2012) First estimates of influenza vaccine effectiveness among severe influenza cases, France, 2011/12. Euro Surveill 17.
9. Mazick A, Gergonne B, Nielsen J, Wuillaume F, Virtanen MJ, et al. (2012) Excess mortality among the elderly in 12 European countries, February and March 2012. Euro Surveill 17.
10. Belchior E (2012) [Epidemiological and virological influenza activity in mainland France: season 2011-2012]. BEH: 424-427.
11. Valleron AJ, Bouvet E, Garnerin P, Menares J, Heard I, et al. (1986) A computer network for the surveillance of communicable diseases: the French experiment. Am J Public Health 76: 1289-1292.
12. Flahault A, Blanchon T, Dorleans Y, Toubiana L, Vibert JF, et al. (2006) Virtual surveillance of communicable diseases: a 20-year experience in France. Stat Methods Med Res 15: 413-421.
13. Fragoso G, de Coronado S, Haber M, Hartel F, Wright L, (2004) Overview and utilization of the NCI thesaurus. Comp Funct Genomics 5: 648-654.
14. Finkelman BS, Viboud C, Koelle K, Ferrari MJ, Bharti N, et al. (2007) Global patterns in seasonal activity of influenza A/H3N2, A/H1N1, and B from 1997 to 2005: viral coexistence and latitudinal gradients. PLoS One 2: e1296.
15. Viboud C, Bjornstad ON, Smith DL, Simonsen L, Miller MA, et al. (2006) Synchrony, waves, and spatial hierarchies in the spread of influenza. Science 312: 447-451.
16. Lemaitre M, Carrat F, Rey G, Miller M, Simonsen L, et al. (2012) Mortality burden of the 2009 A/H1N1 influenza pandemic in France: comparison to seasonal influenza and the A/H3N2 pandemic. PLoS One 7: e45051.
17. Goldstein E, Cobey S, Takahashi S, Miller JC, Lipsitch M, (2011) Predicting the epidemic sizes of influenza A/H1N1, A/H3N2, and B: a statistical method. PLoS medicine 8: e1001051.
18. Dockrey MR, Lober WB, Wolpin SE, Rae LJ, Berry DL (2005) Distributed health assessment and intervention research software framework. AMIA Annu Symp Proc: 940.
19. Pelat C, Lasserre A, Xavier A, Turbelin C, Blanchon T, et al. (2013) Hospitalization of influenza-like illness patients recommended by general practitioners in France between 1997 and 2010. Influenza Other Respi Viruses 7: 74-84.
20. Costagliola D, Flahault A, Galinec D, Garnerin P, Menares J, et al. (1991) A routine tool for detection and assessment of epidemics of influenza-like syndromes in France. Am J Public Health 81: 97-99.
21. Pelat C, Boelle PY, Cowling BJ, Carrat F, Flahault A, et al. (2007) Online detection and quantification of epidemics. BMC Med Inform Decis Mak 7: 29.
22. Lemaitre M, Carrat F, (2010) Comparative age distribution of influenza morbidity and mortality during seasonal influenza epidemics and the 2009 H1N1 pandemic. BMC Infect Dis 10: 162.
23. Breslow NE, Day NE, editors (1980) Statistical Methods in Cancer Research. Volume I- The analysis of case-control studies. Lyon: ARC Scientific Publications. 346 p.
24. Orenstein WA, Bernier RH, Hinman AR, (1988) Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 10: 212-241.
25. Farrington CP, (1993) Estimation of vaccine effectiveness using the screening method. Int J Epidemiol 22: 742-746.
26. Glezen WP, Keitel WA, Taber LH, Piedra PA, Clover RD, et al. (1991) Age distribution of patients with medically-attended illnesses caused by sequential variants of influenza A/H1N1: comparison to age-specific infection rates, 1978-1989. Am J Epidemiol 133: 296-304.
27. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361: 1945-1952.
28. Monto AS, Sullivan KM, (1993) Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 110: 145-160.
29. Fox JP, Cooney MK, Hall CE, Foy HM, (1982) Influenzavirus infections in Seattle families, 1975-1979. II. Pattern of infection in invaded households and relation of age and prior antibody to occurrence of infection and related illness. Am J Epidemiol 116: 228-242.
30. Khiabanian H, Holmes AB, Kelly BJ, Gururaj M, Hripcsak G, et al. (2010) Signs of the 2009 influenza pandemic in the New York-Presbyterian Hospital electronic health records. PLoS One 5.
31. Khiabanian H, Farrell GM, St George K, Rabadan R, (2009) Differences in patient age distribution between influenza A subtypes. PLoS One 4: e6832.
32. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, et al. (2007) Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Med 4: e247.
33. Lee BE, Mukhi SN, Drews SJ, (2010) Association between patient age and influenza A subtype during influenza outbreaks. Infect Control Hosp Epidemiol 31: 535-537.
34. Fleming DM, Zambon M, Bartelds AI, de Jong JC, (1999) The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands. Eur J Epidemiol 15: 467-473.
35. Belongia EA, Kieke BA, Donahue JG, Greenlee RT, Balish A, et al. (2009) Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. J Infect Dis 199: 159-167.
36. Kissling E, Valenciano M (2012) Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 17.
37. Carrat F, Tachet A, Rouzioux C, Housset B, Valleron AJ, (1999) Evaluation of clinical case definitions of influenza: detailed investigation of patients during the 1995-1996 epidemic in France. Clin Infect Dis 28: 283-290.
38. Zambon MC, Stockton JD, Clewley JP, Fleming DM, (2001) Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 358: 1410-1416.
39. Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, et al. (2011) Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France. PLoS One 6: e19621.
40. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA, (2007) Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis 7: 658-666.
41. Linde A, Rotzen-Ostlund M, Zweygberg-Wirgart B, Rubinova S, Brytting M (2009) Does viral interference affect spread of influenza? Euro Surveill 14.
42. Turbelin C, Pelat C, Boelle PY, Levy-Bruhl D, Carrat F, et al. (2009) Early estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases. Euro Surveill 14.
43. Legrand J, Vergu E, Flahault A, (2006) Real-time monitoring of the influenza vaccine field effectiveness. Vaccine 24: 6605-6611.
44. Vaux S, Van Cauteren D, Guthmann JP, Le Strat Y, Vaillant V, et al. (2011) Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey. BMC Public Health 11: 30.